Categories: Clinical TrialNews

SmartSKN Launches K-OWN: The World’s first AI custom Korean skincare platform powered by robots

BOSTON, March 14, 2025 /PRNewswire/ — SmartSKN, a leader in K-Beauty technology, announces the launch of K-OWN. This AI-driven platform empowers consumers to create their own custom Korean skincare tailored to their individual needs.

Redefining Custom Skincare

K-OWN is powered by SmartSKN’s proprietary AI technology, allowing users to build their own skincare formulations based on their unique skin concerns. The platform is integrated with SmartSKN’s robotic mini-labs, which produce freshly made, custom skincare in minutes. This ensures each product is designed for maximum efficacy while minimizing waste.

How It Works

Consumers can access the K-OWN platform through SmartSKN.com and engage in a seamless, step-by-step customization process:

  • Customize – Select a base formulation, choose targeted active ingredients, and adjust oil levels to suit individual skin needs.
  • AI-Optimized Formulation – SmartSKN’s AI technology refines the formula for optimal effectiveness based on skin type and concerns.
  • On-Demand Production – The final formulation is produced in SmartSKN’s robotic mini-labs and shipped directly to the consumer’s door—fresh and customized.

This on-demand approach eliminates overproduction and excess inventory, making K-OWN a more sustainable alternative to mass-produced skincare.

Clinically Proven Skincare with Visible Results

K-OWN formulations are backed by clinical studies demonstrating immediate and measurable improvements in key skin concerns.

In clinical trials, 100% of participants reported:

  • Brighter Skin – Noticeable increase in skin radiance
  • Oil & Shine Control – Reduction in excess oil and smoother texture
  • Firmer, Lifted Appearance – Improved elasticity and skin structure
  • Deep Hydration – Long-lasting moisture retention and nourishment
  • Refined Pores – Visibly smoother and more even skin
  • Stronger Skin Barrier – Enhanced firmness and resilience
  • Calmed Sensitivity – Reduction in redness and improved balance
  • Clearer Skin – Fewer breakouts and enhanced clarity

A Simplified Yet Powerful Routine

The K-OWN product line offers a streamlined three-step skincare system that delivers maximum results with minimal effort:

  • K-OWN Essence Serum – Hydration and foundational skin nourishment
  • K-OWN Ampoule – Targeted treatment for specific skin concerns
  • K-OWN Lotion – Protective moisture barrier for lasting hydration

Skin Empowerment Through Innovation

K-OWN is more than just a skincare line. It’s a revolution in customized beauty. By merging AI-driven precision with robotic manufacturing, SmartSKN Labs is setting a new standard for custom skincare that is efficient, effective, and sustainable.

Val Neicu, CEO and Co-Founder of SmartSKN, states:

“K-OWN puts the power of product creation into the hands of the consumer. It’s the beginning of a new era of customization in beauty, and it is all possible thanks to AI advancements.”

To learn more about K-OWN and experience the future of custom Korean skincare, visit www.smartskn.com.

For media inquiries, contact pr@smartskn.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/smartskn-launches-k-own-the-worlds-first-ai-custom-korean-skincare-platform-powered-by-robots-302402049.html

SOURCE SmartSKN, LLC

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

8 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

11 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

11 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

11 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

11 hours ago